Latest Articles
Inside a “Fake” Conference: A Journey Into Predatory Science
ArticleThere is a growing underbelly of conferences that seem like the real thing but have none of the editorial standards expected by academics and have developed a reputation for advertising with fake agendas and high prices. A chance investigation took us inside one of these predatory conferences and has uncovered how predatory science has ensnared scientists at every level.
READ MORE
Leading Minds Reflect On How the World Feels About Science and Health
ArticleGauging global attitudes to science and health is no easy task, but it was the goal of The Wellcome Global Monitor – a survey of over 140,000 people aged 15 and older, from more than 140 countries. The findings present an unprecedented view of the relationship between science and society worldwide, which were discussed by leaders at the launch event in Washington D.C.
READ MORE
Addressing Gender Bias – “It Is Time to End the Tradition in Science of All-Male Speaking Panels”
ArticleFrancis S. Collins, M.D., Ph.D. Director of the National Institutes of Health, has recently directly addressed the issue of underrepresented groups in science: "Too often, women and members of other groups underrepresented in science are conspicuously missing in the marquee speaking slots at scientific meetings and other high-level conferences.”
READ MORE
Can We Really Measure Stress?
ArticleOxford Medistress, developer of the Leukocyte Coping Capacity (LCC) test, says that the test can measure your stress levels in 10 minutes, by sampling a drop of your blood. Could the test revolutionize the field of stress diagnostics? In this article we explore the history of measuring stress, and find out whether the LCC will be a milestone or side-note in that history.
READ MORE
A Microfluidic Valley Is Growing in Europe, and You’re Invited
ArticleA story of the Elvesys Innovation Unit, a research institute in France designed to unite entrepreneurs involved in microfluidics research.
READ MORE
Promoting Credibility in Neuroscience Research: The 3Rs at the BNA Festival of Neuroscience
ArticleThe British Neuroscience Association's Festival of Neuroscience 2019 put improving research practice and methods at the forefront. In this article, the University of Bath's Naomi Heffer takes a look over why the BNA is promoting research "credibility", and what it means for the neuroscience community.
READ MORE
MeTooSTEM: A Mission to End Sexual Harassment in STEM
ArticleIn the wake of the "Me Too" (or #MeToo) movement, a spotlight has been cast on an additional obstacle that deters many individuals, particularly women, from working in STEM – the astonishingly high incidence of sexual harassment. In this article, we look at the extent of the issue and speak with some of the women that are working tirelessly to combat sexual harassment in STEM through a variety of organizations.
READ MORE
Making Neuroscience More Credible at BNA 2019
ArticleAt the British Neuroscience Association's Festival of Neuroscience 2019, we pulled aside one of the BNA's credibility board, Dr Verena Heise to ask her about credibility in neuroscience, how she became involved in promoting it, and how other players in research can help advance the credibility cause.
READ MORE
Whole-exome Sequencing at the Dawn of Personalized Medicine
ArticleDeciphering the first complete sequence of the human genome in 2003 required a combined effort of scientists from 20 institutions and $3 billion of funding. Over the last decade, whole-exome sequencing (WES) established itself as a method that successfully balances cost and the output of useful data for diagnostic or research applications. Here, we look at how WES is used in both the laboratory and the clinic, and why it is a preferred method of choice in such areas.
READ MORE
Antibodies in Research: The Good, the Bad, and the Validation Epidemic
ArticleThe specificity of antibody binding is incredibly important for many research disciplines, yet sourcing the best antibody for your research can be a challenge. This is partly because not all suppliers validate their antibodies sufficiently. How much of a problem is this?
READ MORE
